Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotechnology Value Fund, L.P. -- Ignore unavailable to you. Want to Upgrade?

To: Mike McFarland who wrote (555)	3/28/1999 12:15:00 AM
From: Mike McFarland	Read Replies (1) \| Respond to of 4974

p.s. --hmmm, I just saw your post which showed that von Emster did okay this past week... Minus 3.5%--very impressive (way to stay ahead of the amex bio index). Maybe he dumped his PathoGenesis before the debacle? Probably not. I have last years annual report, which showed that PGNS was 5.66% of the Franklin Biotech Discovery Fund on 4/30/98. PathoGenesis was the fund's largest holding at that time. Okay, let's see how I do against that Franklin BD fund for the rest of the year. I have the advantage of being able to jump in and out since I will not move the stocks by myself, a serious handicap the fund managers work against. If I cant beat von Emster, I will buy his fund instead of playing in my own brokerage acct. Ready set go.